Connor Butz
Medical · Washington, DCNPI 1821654617
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,876 and has fallen 89.5% since, to $302 in 2025.
Across 181 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$772
- Viiv Healthcare Company$709
- Theratechnologies Inc.$180
- Johnson & Johnson$168
- Takeda Pharmaceuticals U.S.A., Inc.$158
- AbbVie$157
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$1474%
- Food & beverage$3,14794%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 37 | $772 |
| Viiv Healthcare Company | 42 | $709 |
| Theratechnologies Inc. | 9 | $180 |
| Johnson & Johnson | 8 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $158 |
| AbbVie | 8 | $157 |
| Napo Pharmaceuticals Inc | 8 | $147 |
| Biohaven Pharmaceuticals, Inc. | 7 | $139 |
| Lilly USA, LLC | 8 | $123 |
| Pfizer | 7 | $111 |
| Merck | 6 | $95 |
| Clarus Therapeutics Inc. | 7 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Janssen Products, LP | 1 | $65 |
| Jazz Pharmaceuticals Inc. | 3 | $59 |
| Novo Nordisk | 3 | $57 |
| Acerus Pharmaceuticals Corporation | 3 | $55 |
| Kaleo, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| AstraZeneca | 2 | $35 |
| Eisai Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
How this compares
$3,359 in reported general payments places this provider in the 85th percentile of 87 medical providers in District of Columbia.
Other medical in Washington
- Mariella PurvisWashington$13K
- Annise Williams-NairnWashington$8K
- Teylor MartinezWashington$6K
- Hannah SagedyWashington$5K
- Amanda-Gay EdwardsWashington$4K
- Albertina DearingWashington$4K
- Gwendolyn ChallengerWashington$4K
- Susan LelacheurWashington$4K
- Melanie Scott BowlingWashington$3K
- Samineh AsgariWashington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.